BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19543323)

  • 1. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
    Zhou W; Tu Y; Simpson PJ; Kuhajda FP
    Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
    Thupari JN; Pinn ML; Kuhajda FP
    Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
    Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
    Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.
    Pizer ES; Thupari J; Han WF; Pinn ML; Chrest FJ; Frehywot GL; Townsend CA; Kuhajda FP
    Cancer Res; 2000 Jan; 60(2):213-8. PubMed ID: 10667561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
    Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells.
    Brusselmans K; De Schrijver E; Verhoeven G; Swinnen JV
    Cancer Res; 2005 Aug; 65(15):6719-25. PubMed ID: 16061653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.
    Cheng JF; Chen M; Wallace D; Tith S; Haramura M; Liu B; Mak CC; Arrhenius T; Reily S; Brown S; Thorn V; Harmon C; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
    J Med Chem; 2006 Mar; 49(5):1517-25. PubMed ID: 16509570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
    Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
    Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells.
    Bandyopadhyay S; Zhan R; Wang Y; Pai SK; Hirota S; Hosobe S; Takano Y; Saito K; Furuta E; Iiizumi M; Mohinta S; Watabe M; Chalfant C; Watabe K
    Cancer Res; 2006 Jun; 66(11):5934-40. PubMed ID: 16740734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
    Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
    Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
    Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
    Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly sensitive high-throughput luminescence assay for malonyl-CoA decarboxylase.
    Lo MC; Wang M; Kim KW; Busby J; Yamane H; Zondlo J; Yuan C; Young SW; Xiao SH
    Anal Biochem; 2008 May; 376(1):122-30. PubMed ID: 18294446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
    Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors.
    Cheng JF; Chen M; Liu B; Hou Z; Arrhenius T; Nadzan AM
    Bioorg Med Chem Lett; 2006 Feb; 16(3):695-700. PubMed ID: 16257202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.
    Chajès V; Cambot M; Moreau K; Lenoir GM; Joulin V
    Cancer Res; 2006 May; 66(10):5287-94. PubMed ID: 16707454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of fatty acid synthase for lung cancer treatment.
    Orita H; Coulter J; Lemmon C; Tully E; Vadlamudi A; Medghalchi SM; Kuhajda FP; Gabrielson E
    Clin Cancer Res; 2007 Dec; 13(23):7139-45. PubMed ID: 18056164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.